More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$6.25B
EPS
-0.81
P/E ratio
--
Price to sales
0.84
Dividend yield
--
Beta
0.970692
Previous close
$9.52
Today's open
$9.53
Day's range
$9.04 - $9.53
52 week range
$7.27 - $15.93
show more
CEO
Emmanuel Ligner
Employees
13500
Headquarters
Radnor, PA
Exchange
New York Stock Exchange
Shares outstanding
682755402
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • May 29, 2026

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
Zacks Investment Research • May 29, 2026

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
RADNOR, Pa., May 19, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.
PRNewsWire • May 19, 2026

The Broyhill Q1 2026 Portfolio Strategy And Positioning
Valvoline was Broyhill's largest contributor in the quarter, as the underlying unit economics are intact, while unit growth, service mix, and price continue moving in the same direction. Honeywell management accelerated the aerospace spin-off to the end of June, leaving behind a pure-play automation business that Broyhill believes is worth meaningfully more than the whole. Large pharma is structurally reliant on IQVIA's clinical trial architecture and proprietary data assets, and Broyhill thinks it is highly unlikely that AI can automate away the FDA approval process.
Seeking Alpha • May 15, 2026

Diamond Hill Capital Management Mid Cap Strategy Q1 2026 Drivers And Decisions
Regal Rexnord outperformed in Q1 as the company reported strong orders for a new data center product, which should support solid revenue growth in 2027. Diamond Hill initiated a position in Antero Resources, a natural gas exploration and production company, to gain exposure given a constructive long-term outlook for US natural gas. Carrier Global is now a focused, high-quality business that Diamond Hill believes is in an excellent position to continue to gain market share and improve margins long-term.
Seeking Alpha • May 8, 2026

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity
We do not believe Humana's current share price reflects the company's earnings power, and as industry conditions normalize, we believe it can return to target margins over the long term. We initiated a position in Antero Resources, a natural gas exploration and production company, to gain exposure given our constructive long-term outlook for US natural gas. We exited our position in First Advantage, a leader in the background check space, to pursue other opportunities with less macro exposure and AI-disruption concerns.
Seeking Alpha • May 7, 2026

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible
Avantor, Inc. reported a slight beat on 1Q26 EPS and revenue, but underlying organic growth and margins remain under pressure. Negative organic growth, margin compression, and subdued cash flow signal only early stabilization, not a confirmed recovery, especially in the VWR segment. Management reaffirmed 2026 guidance and expects sequential improvement, but the recovery is execution-dependent and gradual, with margins likely to remain below historical peaks.
Seeking Alpha • Apr 30, 2026

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline
AVTR benefits from stable Q1 revenues and improving demand trends, though margin pressure and volume softness weigh on profitability.
Zacks Investment Research • Apr 30, 2026

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript
Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript
Seeking Alpha • Apr 29, 2026

Avantor® Reports First Quarter 2026 Results
Net sales of $1,581 million Net income of $43 million; Adjusted EBITDA of $219 million Diluted GAAP EPS of $0.06; adjusted EPS of $0.17 Operating cash flow of $59 million; free cash flow of $25 million Reaffirms FY 2026 guidance RADNOR, Pa., April 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2026.
PRNewsWire • Apr 29, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Avantor Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.